Protein Expression Service
With 12,000+ recombinant proteins delivered and a 90% project success rate, BioCrest Sci provides expert production of challenging targets — transmembrane proteins, kinases, enzymes, and viral antigens. Our proteins support drug discovery, antibody development, ELISA, structural biology, enzyme assays, and cell-based studies.
Why BioCrest Sci
Protein Expression Systems
✔ Fastest (3–5 weeks)
✔ Low cost, high yield
⚠ No glycosylation, possible solubility issues
✔ Eukaryotic folding, moderate glycosylation
✔ Gram‑scale production
⚠ Longer optimization for secreted proteins
✔ Scalable, high safety
✔ Suitable for multimeric & some membrane proteins
⚠ Glycosylation differs from mammals
✔ Native conformation, full glycosylation
✔ Secreted expression, easy purification
⚠ Higher cost, longer timeline
✔ Full-length membrane proteins (GPCRs, ion channels, transporters)
✔ Multiple display platforms available
✔ Native or near-native conformation
✔ Rapid protein synthesis without live cells
✔ Ideal for toxic or membrane proteins
✔ High-throughput screening compatible
Transmembrane Protein Display Platforms
VLP Platform
Displayed Transmembrane Proteins
Virus-like particle platform for membrane protein presentation in native-like environment
Detergent Platform
Displayed Transmembrane Proteins
Detergent-solubilized membrane proteins for biochemical and structural studies
Synthetic Nanodisc Platform
Displayed Transmembrane Proteins
Synthetic nanodisc-embedded membrane proteins for maximal stability and functionality
Expression System Selection Guide
| Primary Priority | Recombinant System | Turnaround Time | Relative Cost | Key Limitation | Main Applications |
|---|---|---|---|---|---|
| Fastest protein acquisition | Bacterial (E. coli) | 3–5 weeks | Low | No glycosylation; solubility | Antigens, cytosolic proteins, enzymes |
| Native conformation & glycosylation | Mammalian | 6–8 weeks | High | Lower expression yield | Therapeutic targets, functional studies, antibodies |
| Membrane proteins / VLPs | Insect (Baculovirus) | 6–8 weeks | Medium | Scale‑up complexity | Vaccine development, structural studies |
| Full-length transmembrane proteins | VLP / Detergent / Nanodisc / Cell-Free | 4–8 weeks | Medium-High | Platform selection critical | GPCRs, ion channels, transporters, functional analysis |
| Toxic or difficult proteins | Cell-Free | 2–4 weeks | Medium | Limited for large-scale | Toxic proteins, membrane proteins, rapid screening |
Service Process
Frequently Asked Questions
Featured Success
Mammalian system + Nanodisc platform → high-purity, ligand binding confirmed.
Insect system → 50+ mg/L, used in ELISA kits worldwide.
Cell-free system → rapid expression, active conformation achieved.
Mammalian expression + VLP display → functional for antibody screening.
Email: protein@biocrest.com | Fast response within 24h
© BioCrest Sci — One-stop protein & antibody solutions